Pulmonx Corporation Common Stock (LUNG) Stock Price

LUNGStock

$2.50+34.91%52W

Market Cap$107.37M

P/E—

PEG Ratio—

Div yield—

Beta0.28

LUNG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)49.32%

Price vs S&P 500 (4W)79.35%

VGM Score66.21

Book Value / Share (Quarterly)$0.91

P/TBV (Annual)3.12x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)19.03%

Cash Flow / Share (Quarterly)$-0.71

Price vs S&P 500 (YTD)-8.79%

Gross Margin (TTM)77.06%

Net Profit Margin (TTM)-55.03%

EPS (TTM)$-1.16

10-Day Avg Trading Volume0.50M

EPS Excl Extra (TTM)$-1.16

Revenue Growth (5Y)22.56%

EPS (Annual)$-1.33

ROI (Annual)-59.21%

Gross Margin (Annual)74.19%

Net Profit Margin (5Y Avg)-85.17%

Cash / Share (Quarterly)$1.30

Revenue Growth QoQ (YoY)-4.62%

ROA (Last FY)-41.77%

Revenue Growth TTM (YoY)-3.43%

EBITD / Share (TTM)$-1.09

ROE (5Y Avg)-56.08%

Operating Margin (TTM)-52.96%

Cash Flow / Share (Annual)$-0.79

P/B Ratio2.46x

P/B Ratio (Quarterly)1.40x

Net Income / Employee (Annual)$-182,400

EV / Revenue (TTM)0.89x

Net Interest Coverage (TTM)-45.91x

ROA (TTM)-38.32%

EPS Incl Extra (Annual)$-1.33

Current Ratio (Annual)5.07x

Quick Ratio (Quarterly)3.37x

3-Month Avg Trading Volume0.56M

52-Week Price Return34.91%

Revenue / Employee (TTM)$295,400

Tangible BV / Share (Quarterly)$2.16

P/S Ratio (Annual)1.07x

Asset Turnover (Annual)0.70x

52-Week High$2.89

Operating Margin (5Y Avg)-85.07%

EPS Excl Extra (Annual)$-1.33

CapEx CAGR (5Y)-13.06%

26-Week Price Return60.56%

Quick Ratio (Annual)4.15x

13-Week Price Return48.05%

Total Debt / Equity (Annual)0.69x

Current Ratio (Quarterly)4.32x

Enterprise Value$78.11M

Revenue / Share Growth (5Y)19.39%

Asset Turnover (TTM)0.70x

Book Value / Share Growth (5Y)-27.16%

Revenue / Employee (Annual)$305,700

Inventory Turnover (Annual)1.43x

Pretax Margin (Annual)-58.98%

Cash / Share (Annual)$1.67

3-Month Return Std Dev111.25%

Gross Margin (5Y Avg)74.00%

Net Income / Employee (TTM)$-162,600

ROE (Last FY)-99.79%

Net Interest Coverage (Annual)-20.81x

EPS Basic Excl Extra (Annual)$-1.33

Receivables Turnover (TTM)6.21x

Total Debt / Equity (Quarterly)0.96x

EPS Incl Extra (TTM)$-1.16

Receivables Turnover (Annual)7.18x

ROI (TTM)-55.28%

P/S Ratio (TTM)1.10x

Pretax Margin (5Y Avg)-84.48%

Revenue / Share (Annual)$2.22

Tangible BV / Share (Annual)$2.16

Price vs S&P 500 (52W)16.60%

Year-to-Date Return3.17%

5-Day Price Return0.89%

EPS Normalized (Annual)$-1.33

ROA (5Y Avg)-32.35%

Net Profit Margin (Annual)-59.67%

Month-to-Date Return39.88%

Cash Flow / Share (TTM)$-1.58

EBITD / Share (Annual)$-1.29

Operating Margin (Annual)-59.30%

LT Debt / Equity (Annual)0.68x

ROI (5Y Avg)-40.34%

LT Debt / Equity (Quarterly)0.95x

EPS Basic Excl Extra (TTM)$-1.16

P/TBV (Quarterly)3.12x

P/B Ratio (Annual)1.68x

Inventory Turnover (TTM)1.23x

Pretax Margin (TTM)-54.34%

Book Value / Share (Annual)$1.30

Price vs S&P 500 (13W)45.26%

Beta0.28x

Revenue / Share (TTM)$2.06

ROE (TTM)-96.66%

52-Week Low$1.13

vGradeB

gGradeC

mGradeA

vgmGradeB

LUNG Earnings Surprise History

Q2 25-0.38est. -0.40

Q3 25-0.34est. -0.42

Q4 25-0.25est. -0.39

Q1 26-0.33est. -0.33

Q2 26-0.24est. -0.28

LUNG Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
LUNGPulmonx Corporation Common Stock	B	C	A	$2.50
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Pulmonx Corporation Common Stock

Pulmonx develops minimally invasive treatments for severe emphysema and COPD, with its flagship Zephyr Endobronchial Valve supported by diagnostic assessment platforms. The company sells its medical devices to hospitals and distributors across the U.S., Europe, Middle East, Africa, and Asia Pacific. Pulmonx serves patients with limited treatment options in a significant respiratory disease market.